echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Base construction paves the way for Gansu Fuzheng pharmaceutical industry to enter the fast lane of industrialization

    Base construction paves the way for Gansu Fuzheng pharmaceutical industry to enter the fast lane of industrialization

    • Last Update: 2018-06-28
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    [China Pharmaceutical network enterprise news] a few days ago, the "2017 China pharmaceutical industry influential list conference and 2018 China (Lanzhou) Pharmaceutical Industry Development Summit Forum" hosted by the all China Federation of industry and Commerce medical and pharmaceutical chamber of Commerce was held in Lanzhou, Gansu Province At the meeting, the influential list of China's pharmaceutical industry in 2017 was released Gansu Fuzheng Pharmaceutical Technology Co., Ltd (hereinafter referred to as Fuzheng pharmaceutical) won three honors, namely, "top 50 growth enterprises of China's pharmaceutical industry in 2017", "law-abiding and honest enterprises of China's pharmaceutical industry in 2017" and "top 10 standardized planting bases of China's authentic Chinese herbal medicine in 2017" As a local enterprise in Gansu Province, Fuzheng pharmaceutical industry not only relies on resource advantages for innovation and development, but also has been committed to the poverty alleviation work of traditional Chinese medicine industry, which has achieved remarkable results and won market reputation After 50 years of development from restructuring to collectivization, Fuzheng pharmaceutical was formerly founded in 1970 in Dingxi pharmaceutical factory of Gansu Province, and in 2005 it was transformed into a joint-stock private enterprise controlled by Beijing haijixing Medical Technology Co., Ltd After nearly 50 years of development, the company has grown into a comprehensive group company integrating the R & D, production and sales of drugs, food and large health products Its subsidiaries include Gansu Lanyao Pharmaceutical Co., Ltd., Gansu Zhenqi Fuzheng Research Co., Ltd., Gansu Longxi traditional Chinese Medicine Industry Development Co., Ltd., Lanzhou Fuzheng Pharmaceutical Marketing Co., Ltd and Tibet Fuzheng Pharmaceutical Co., Ltd And other five wholly-owned subsidiaries Since 2005, it has been transformed into a joint-stock private enterprise, which has entered a high-speed development stage The pharmaceutical industry has invested a lot of funds in the industrial layout Now it has formed a pattern of "Beijing Yizhuang product R & D center + Lanzhou new area chemical medicine production base + Dingxi chankou traditional Chinese Medicine production base + Longxi big health product production base" Since the reform and opening up, under the guidance of the industrial policy of traditional Chinese medicine, Fuzheng pharmaceutical industry, relying on the advantage resources of local medicinal materials, has focused on the industrialization of genuine and characteristic medicinal materials in Gansu Province, starting with the core product of Gansu Zhenqi Fuzheng pharmaceutical Through resource integration, technological transformation and mechanism innovation, the development foundation has been consolidated, the industrial layout has been optimized, the industrial chain has been extended, a comprehensive marketing network with clear levels has been formed, and the markets of Southeast Asia and the United States have been expanded on the basis of the original overseas markets   Yang Jun, founder investor of Fuzheng pharmaceutical and chairman of Beijing haijixing, said that in the future, Fuzheng pharmaceutical will mainly carry out the research and development of traditional Chinese medicine health care products, the development of hospital preparations with exact curative effect and the large-scale production research of traditional Chinese medicine formula particles, focusing on the construction of Longxi traditional Chinese medicine circular economy industrial park, Longyao preparation technology research and development and application industrialization base The construction project will promote the upgrading of Longyao industry in Dingxi and help the poor We will continue to promote the standardization and standardized cultivation of genuine medicinal materials, and strive to improve the base construction of Astragalus, dangshen, angelica, rhubarb and liquorice, so as to guarantee the development of traditional Chinese medicine Focus on poor households to promote industrial poverty alleviation and get actual results Over the years, Fuzheng pharmaceutical industry has been committed to poverty alleviation in the traditional Chinese medicine industry Not only through the cooperation mode of "company + base + farmer", but also through regular training and field guidance on the cultivation technology of traditional Chinese medicine for the farmers of traditional Chinese medicine planting, to improve the knowledge and skills of pharmaceutical farmers and focus poverty alleviation on the traditional Chinese medicine industry and skills improvement With the continuous deepening of base construction in recent years, the company has established a good cooperative relationship with drug farmers in major drug producing areas of Gansu Province, accumulatively helping and promoting farmers to more than 10000, training farmers 13000 person times, and distributing more than 1 million agricultural funds In addition, Fuzheng pharmaceutical also strives to tap the income potential of the poor and rich peasants Each year, more than 1300 mu of Gongjing land is transferred, so that the poor peasants who transfer the land can work locally in the base of traditional Chinese medicine planted by Fuzheng pharmaceutical, such as weeding and fertilization, to increase their income Poor households can also learn the planting technology of traditional Chinese medicine, and reserve knowledge and experience for the future development of traditional Chinese medicine industry and expansion of planting scale The growers can rely on supporting the pharmaceutical industry to solve the sales problems, and effectively promote the local planting cooperatives and large growers to further develop the traditional Chinese medicine industry With the improvement of the planting level of poor households and the quality of traditional Chinese medicine products, as well as the increase of market demand for traditional Chinese medicine, the sales price of products will increase year by year, making the income of poor households will continue to increase, reaching an annual income of more than 3000 yuan Through the traditional Chinese medicine industry, poverty alleviation will be realized, and the enthusiasm of the masses for planting traditional Chinese medicine will also rise According to the introduction, Fuzheng pharmaceutical is the main supporting unit of Gansu Province Traditional Chinese medicine modernization engineering technology research center and Gansu Provincial Road traditional Chinese medicine modernization Engineering Research Center, and has authorized 18 projects In 2018, it is planned to invest more than 20 million yuan in the project planning and construction of standardized planting, large-scale storage, refined processing and marketing, so as to seek long-term development Fuzheng pharmaceutical has given full play to the advantages of pure medicinal materials in Gansu Province The 3080 Mu Astragalus standardized planting base established in Biyan town of Longxi has passed the national GAP certification and authentic medicine certification, and the standardized planting base has been established in Huichuan town of Weiyuan County The standardized planting base of liquorice, an endangered traditional Chinese medicine in the north mountain of Yuzhong, has been built by the way of "land transfer, self cultivation and self planting" It is planned to gradually build a standardized planting base of "ten Longyao" of Dangshen, Danggui, rhubarb, Scutellaria, isatis root, fangdonghua, bupleurum, wolfberry, Astragalus and liquorice in the future, select seeds and seedlings of genuine medicinal materials, and form a large-scale planting of 200000 mu of genuine medicinal materials In addition, Fuzheng pharmaceutical also invested a lot of energy in the research and development of pharmaceutical preparation technology and application industrialization development base, the investment of 160 million yuan in the research and industrial development of traditional Chinese medicine formula particles, and the construction of anti-tumor drug base, laying a foundation for long-term development "In terms of the cultivation of genuine medicinal materials and industrial development, we will also cooperate with a number of colleges and universities to promote the combination of production, learning and research, and step into the development fast lane of standardized planting, large-scale storage, refined processing and marketing." Yang Jun said.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.